DNA Brands Statistics
Total Valuation
DNA Brands has a market cap or net worth of 323,479.
| Market Cap | 323,479 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
DNA Brands has 3.23 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 3.23B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 14.54% |
| Revenue Per Employee | 124,507 |
| Profits Per Employee | -622,736 |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.76% in the last 52 weeks. The beta is 1.43, so DNA Brands's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -82.76% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 45.42 |
| Average Volume (20 Days) | 1,158,755 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, DNA Brands had revenue of 249,013 and -1.25 million in losses. Loss per share was -0.28.
| Revenue | 249,013 |
| Gross Profit | 249,013 |
| Operating Income | -243,528 |
| Pretax Income | -1.25M |
| Net Income | -1.25M |
| EBITDA | -239,664 |
| EBIT | -243,528 |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 14,577 in cash and 2.14 million in debt, giving a net cash position of -2.12 million or -0.00 per share.
| Cash & Cash Equivalents | 14,577 |
| Total Debt | 2.14M |
| Net Cash | -2.12M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.67M |
| Book Value Per Share | -0.92 |
| Working Capital | -2.69M |
Cash Flow
| Operating Cash Flow | -1.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -97.80% |
| Pretax Margin | -500.16% |
| Profit Margin | n/a |
| EBITDA Margin | -96.25% |
| EBIT Margin | -97.80% |
| FCF Margin | n/a |
Dividends & Yields
DNA Brands does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11,406.64% |
| Shareholder Yield | -11,406.64% |
| Earnings Yield | -385.02% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.005.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.005 |
Scores
DNA Brands has an Altman Z-Score of -46.91. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -46.91 |
| Piotroski F-Score | n/a |